Medical Economics July 26, 2024
Open meeting to be held online Aug. 1; independent pharmacies, PBM trade group offer responses to federal reviews.
The hot seat in Washington, D.C., could get hotter for pharmacy benefit managers (PBMs) when the Federal Trade Commission (FTC) meets next week to discuss its recent report on the drug price middle men.
Meanwhile, a consortium of pharmacy groups is demanding federal lawmakers pass reforms they say are needed to regain control of the pharmaceutical market. A PBM trade group countered that legislators need a balanced and accurate discussion, not just repetition of claims of Big Pharma, which stands to benefit if PBMs lose their price bargaining power.
As public discourse about PBMs at times rises to a clamor, the FTC...
Today's Sponsors
Today's Sponsor